Principal, Washington, DC, New Enterprise Associates
Jason joined NEA as a Principal in 2014 and focuses on investments in biopharmaceuticals. Prior to joining NEA, Jason was a Principal with Third Rock Ventures were he contributed to the creation and management of several companies, including NinePoint Medical, Kala Pharmaceuticals and most recently, Jounce Therapeutics where he served as Director of Corporate development after helping found the company. Jason earned his PhD at MIT under the supervision of Robert Langer as an NSF fellow, and received an MPhil from the University of Cambridge where he was a Churchill Scholar. He also holds a BS in Chemical Engineering from Michigan State University.